Volume 2, Issue 5, Pages 413-421 (May 2015) Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis Dr Marit Sijbrandij, PhD, Annet Kleiboer, PhD, Jonathan I Bisson, DM, Corrado Barbui, MD, Pim Cuijpers, PhD The Lancet Psychiatry Volume 2, Issue 5, Pages 413-421 (May 2015) DOI: 10.1016/S2215-0366(14)00121-7 Copyright © 2015 Elsevier Ltd Terms and Conditions
Figure 1 Study selection The Lancet Psychiatry 2015 2, 413-421DOI: (10.1016/S2215-0366(14)00121-7) Copyright © 2015 Elsevier Ltd Terms and Conditions
Figure 2 Standardised effect sizes of pharmacological prevention for PTSD compared with control groups: incidence risk ratio IRR=incidence risk ratio. PTSD=post-traumatic stress disorder. ASD=acute stress disorder. SG=sequence generation. AC=allocation concealment. BA=blinded outcome assessment. ITT=intention to treat. NA=not applicable. *Data of the first assessment only. †Overall quality score. The Lancet Psychiatry 2015 2, 413-421DOI: (10.1016/S2215-0366(14)00121-7) Copyright © 2015 Elsevier Ltd Terms and Conditions